Literature DB >> 17895932

Therapy insight: What nephrologists need to know about primary vesicoureteral reflux.

Patricio C Gargollo1, David A Diamond.   

Abstract

Vesicoureteral reflux (VUR) is the abnormal, retrograde flow of urine from the bladder to the upper urinary tract. This disease affects about 1% of otherwise normal children, 30-50% of those who present with urinary tract infections, and approximately 10% with prenatally diagnosed hydronephrosis. Over the past 50 years, tremendous progress has been made in the diagnosis, treatment and management of VUR. The realization that VUR is probably a component of generalized dysfunction of the lower urinary tract (i.e. dysfunctional elimination syndrome) has further enhanced understanding of the disease. This Review covers basic pathogenesis, diagnosis, management, clinical presentation, and current controversies surrounding VUR.

Entities:  

Mesh:

Year:  2007        PMID: 17895932     DOI: 10.1038/ncpneph0610

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  11 in total

1.  Evaluation of dynamic contrast-enhanced MRI in detecting renal scarring in a rat injury model.

Authors:  Bingyin Wang; Graham Sommer; Daniel Spielman; Linda M Dairiki Shortliffe
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

2.  Electrolyte disturbances in acute pyelonephritis.

Authors:  Maite Augusta Gil-Ruiz; Andrés José Alcaraz; Rafael José Marañón; Nelia Navarro; Belén Huidobro; Augusto Luque
Journal:  Pediatr Nephrol       Date:  2011-10-08       Impact factor: 3.714

Review 3.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

4.  Does routine ultrasound change management in the follow-up of patients with vesicoureteral reflux?

Authors:  Jan K Rudzinski; Bryce Weber; Petra Wildgoose; Armando Lorenzo; Darius Bagli; Walid Farhat; Elizabeth Harvey; Joao Luiz Pippi Salle
Journal:  Can Urol Assoc J       Date:  2013 Jul-Aug       Impact factor: 1.862

5.  Postoperative ureteral obstruction after endoscopic treatment for vesicoureteral reflux.

Authors:  Jae Min Chung; Chang Soo Park; Sang Don Lee
Journal:  Korean J Urol       Date:  2015-07-01

6.  Analysis of the IL-10, IL-12, and TNF-α Gene Polymorphisms in Patients With Vesicoureteral Reflux Among the Southeast Iranian Population.

Authors:  Dor Mohammad Kordi Tamandani; Nasim Naeimi; Ali Ghasemi; Taybe Baranzahi; Simin Sadeghi-Bojd
Journal:  Nephrourol Mon       Date:  2016-03-12

7.  Genome-wide linkage and association study implicates the 10q26 region as a major genetic contributor to primary nonsyndromic vesicoureteric reflux.

Authors:  John M Darlow; Rebecca Darlay; Mark G Dobson; Aisling Stewart; Pimphen Charoen; Jennifer Southgate; Simon C Baker; Yaobo Xu; Manuela Hunziker; Heather J Lambert; Andrew J Green; Mauro Santibanez-Koref; John A Sayer; Timothy H J Goodship; Prem Puri; Adrian S Woolf; Rajko B Kenda; David E Barton; Heather J Cordell
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

8.  Antibiotic prophylaxis for children with primary vesicoureteral reflux: where do we stand today?

Authors:  Michiel Costers; Rita Van Damme-Lombaerts; Elena Levtchenko; Guy Bogaert
Journal:  Adv Urol       Date:  2008

9.  Vesicoureteral reflux, reflux nephropathy, and end-stage renal disease.

Authors:  Paul Brakeman
Journal:  Adv Urol       Date:  2008

10.  A new genome scan for primary nonsyndromic vesicoureteric reflux emphasizes high genetic heterogeneity and shows linkage and association with various genes already implicated in urinary tract development.

Authors:  J M Darlow; M G Dobson; R Darlay; C M Molony; M Hunziker; A J Green; H J Cordell; P Puri; D E Barton
Journal:  Mol Genet Genomic Med       Date:  2013-07-07       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.